Fasting Research

While water fasting has enjoyed wide practice, there has been only limited scientific research documenting its efficacy and safety.  One of the principle goals of the NHA has been to document scientifically the benefits and safety of fasting, and towards this end, has raised  money to help fund research studies being conducted by Dr. Alan Goldhamer.

In June 2001, Dr. Goldhamer and his staff at the True North Health Center completed a 12 year study in conjuction with his colleagues at Cornell University.  The study was published in the scientific, peer-reviewed and indexed, Journal of Manipulative and Physiological Therapeutics. This paper, entitled Medically Supervised Water-only Fasting in the Treatment of Hypertension, detailed their outstanding results in the treatment of 174 consecutive program participants presenting with high blood pressure.  Read the study about Fasting as a Treatment for Hypertension.

The above study demonstrated the remarkable effectiveness of water-only fasting in the treatment of the leading contributing cause of morbidity and mortality in industrialized countries.  A second study evaluating the effectiveness of fasting in the treatment of borderline high blood pressure was accepted for publiscion and appeared in the October 2002 issue of the Journal of Alternative and Complimentary Medicine.  Read the study about Fasting as a Treatment of Borderline Hypertension.

Currently the NHA has provided signifcant funding for a Fasting Safety Study being conducted by Dr. Goldhamer.   For the past 5 years, Dr. Goldhamer and his staff have been meticulously collecting date on almost 2000 patients that have undergone medically supervised water-only fasting.  The data analysis has been performed by a Research Scientist, Dr. John and is awaiting acceptance for publication.  It is the hope of the NHA that this paper dealing with the safety of fastin will open the door to funding fro the government and privte funding agencies and make it possible for the research team at True North Health and others to conduct clinical trials on the use of fasting in cardiovascular disease, autoimmune disease and diabetes.